Charles River (CRL) CEVP Shannon Parisotto Exercises Options, Sells Shares

What Happened
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories (CRL), exercised 2,039 stock options and immediately sold the 2,039 shares on Aug 19, 2026. The exercise recorded an acquisition value of $395,811 (2,039 shares @ $194.12). The simultaneous sale was executed at $294.12 per share for total sale proceeds of $599,711. The filings show the derivative conversion associated with the exercise (reported as disposed at $0), which is typical when options are converted into shares that are then sold.

Key Details

• Transaction date: 2026-08-19 (reported on Form 4 filed 2026-08-20).
• Exercise (M): 2,039 shares acquired at $194.12 — $395,811 total cost.
• Sale (S): 2,039 shares sold at $294.12 — $599,711 total proceeds.
• Derivative line: 2,039 shares reported disposed at $0 (reflects conversion/exercise).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Transactions occurred pursuant to a Rule 10b5‑1 trading plan adopted March 4, 2026.
• Filing timeliness: Report filed the day after the transaction (appears timely; no late filing indicated).

Context
This was a coordinated exercise-and-sale (cashless-style) under a pre-established 10b5‑1 plan — a common mechanism that allows insiders to sell shares at predetermined times. Sales like this are generally routine and reflect execution under the trading plan rather than an explicit public signal about company prospects.